259 related articles for article (PubMed ID: 36474135)
41. Development and validation of a risk stratification score for new-onset atrial fibrillation in STEMI patients undergoing primary percutaneous coronary intervention.
Mazzone A; Scalese M; Paradossi U; Del Turco S; Botto N; De Caterina A; Trianni G; Ravani M; Rizza A; Molinaro S; Palmieri C; Berti S; Basta G
Int J Clin Pract; 2018 Apr; 72(4):e13087. PubMed ID: 29665154
[TBL] [Abstract][Full Text] [Related]
42. Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Han K; Shi D; Yang L; Wang Z; Li Y; Gao F; Liu Y; Ma X; Zhou Y
Ann Med; 2022 Dec; 54(1):1667-1677. PubMed ID: 35695557
[TBL] [Abstract][Full Text] [Related]
43. Systemic inflammation response index is associated MACE in patients with NSTEMI.
Ozilhan MO; Çakmak Karaaslan O; Acikgoz SK; Selcuk H; Selcuk MT; Maden O
Eur Rev Med Pharmacol Sci; 2023 Sep; 27(18):8588-8597. PubMed ID: 37782174
[TBL] [Abstract][Full Text] [Related]
44. Association of Systemic Inflammatory Response Index and Pan-Immune-Inflammation-Value with Long-Term Adverse Cardiovascular Events in ST-Segment Elevation Myocardial Infarction Patients After Primary Percutaneous Coronary Intervention.
Liu Y; Liu J; Liu L; Cao S; Jin T; Chen L; Wu G; Zong G
J Inflamm Res; 2023; 16():3437-3454. PubMed ID: 37600225
[TBL] [Abstract][Full Text] [Related]
45. B-type natriuretic peptide predicts new-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
Asanin M; Stankovic S; Mrdovic I; Matic D; Savic L; Majkic-Singh N; Ostojic M; Vasiljevic Z
Peptides; 2012 May; 35(1):74-7. PubMed ID: 22421508
[TBL] [Abstract][Full Text] [Related]
46. The value of syntax score to predict new-onset atrial fibrillation in patients with acute coronary syndrome.
Cirakoglu OF; Aslan AO; Akyuz AR; Kul S; Şahin S; Korkmaz L; Sayın MR
Ann Noninvasive Electrocardiol; 2019 Jul; 24(4):e12622. PubMed ID: 30615236
[TBL] [Abstract][Full Text] [Related]
47. The use of systemic immune-inflammation index to predict new onset atrial fibrillation in the context of acute coronary syndrome.
Sayın MR; Özderya A; Konuş AH; Yerlikaya MG; Maz MA; Çırakoğlu ÖF; Uzun G; Kara F
Kardiologiia; 2022 Aug; 62(8):59-64. PubMed ID: 36066989
[TBL] [Abstract][Full Text] [Related]
48. Association of stress hyperglycemia ratio with in-hospital new-onset atrial fibrillation and long-term outcomes in patients with acute myocardial infarction.
Luo J; Li Z; Qin X; Zhang X; Liu X; Zhang W; Xu W; Liu B; Wei Y;
Diabetes Metab Res Rev; 2024 Feb; 40(2):e3726. PubMed ID: 37712510
[TBL] [Abstract][Full Text] [Related]
49. Value of systemic inflammation-response index in predicting contrast-induced nephropathy in patients with ST-elevation myocardial infarction.
Yildiz C; Yuksel Y; Efe SC; Altintas MS; Katkat F; Ayca B; Karabulut D; Çağlar FNT; Köse S
Acta Cardiol; 2023 Oct; 78(8):930-936. PubMed ID: 37293996
[TBL] [Abstract][Full Text] [Related]
50. Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial).
Rene AG; Généreux P; Ezekowitz M; Kirtane AJ; Xu K; Mehran R; Brener SJ; Stone GW
Am J Cardiol; 2014 Jan; 113(2):236-42. PubMed ID: 24176066
[TBL] [Abstract][Full Text] [Related]
51. Stress hyperglycemia ratio and neutrophil to lymphocyte ratio are reliable predictors of new-onset atrial fibrillation in patients with acute myocardial infarction.
Pan L; Li Z; Li C; Dong X; Hidru TH; Liu F; Xia Y; Yang X; Zhong L; Liu Y
Front Cardiovasc Med; 2022; 9():1051078. PubMed ID: 36440053
[TBL] [Abstract][Full Text] [Related]
52. MELD-XI score predict no-reflow phenomenon and short-term mortality in patient with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Zhang XT; Lin ZR; Zhang L; Zhao ZW; Chen LL
BMC Cardiovasc Disord; 2022 Mar; 22(1):113. PubMed ID: 35300593
[TBL] [Abstract][Full Text] [Related]
53. The neutrophil-to-lymphocyte ratio is associated with bare-metal stent restenosis in STEMI patients treated with primary PCI.
Bolca O; Güngör B; Özcan KS; Karadeniz FÖ; Sungur A; Köroğlu B; Bakhshyaliyev N; Yelgeç NS; Karataş B; İpek G; Yilmaz H; Öztürk R
Coron Artery Dis; 2015 Aug; 26(5):402-8. PubMed ID: 25919903
[TBL] [Abstract][Full Text] [Related]
54. New-onset atrial fibrillation after percutaneous coronary intervention or coronary artery bypass grafting for left main disease.
Avdagić H; Iveljić I; Jahić E; Sijerčić S; Krdžalić A; Skakić A; Radović J; Ahmetašević E
Med Glas (Zenica); 2019 Aug; 16(2):. PubMed ID: 30997784
[TBL] [Abstract][Full Text] [Related]
55. Prognostic Impact of the Symptom of New-Onset Atrial Fibrillation in Acute Myocardial Infarction: Insights From the NOAFCAMI-SH Registry.
Luo J; Liu B; Li H; Xu S; Gong M; Li Z; Qin X; Shi B; Hao C; Zhang J; Wei Y
Front Cardiovasc Med; 2021; 8():677695. PubMed ID: 34631808
[No Abstract] [Full Text] [Related]
56. The role of myocardial work in evaluating coronary microcirculation of STEMI patients after percutaneous coronary intervention.
Ruizhong L; Yanhong L; Fei W; Yushi W; Yuqiong L
Echocardiography; 2021 Dec; 38(12):2060-2068. PubMed ID: 34841596
[TBL] [Abstract][Full Text] [Related]
57. Association of lipopolysaccharide with new-onset atrial fibrillation in ST-segment elevation myocardial infarction.
Ren H; Wang Z; Li Y; Liu J
Heliyon; 2024 Mar; 10(6):e27552. PubMed ID: 38496897
[TBL] [Abstract][Full Text] [Related]
58. Lipid Profile and New-Onset Atrial Fibrillation in Patients With Acute ST-Segment Elevation Myocardial Infarction (An Observational Study in Southwest of China).
Xue Y; Zhou Q; Shen J; Liu G; Zhou W; Wen Y; Luo S
Am J Cardiol; 2019 Nov; 124(10):1512-1517. PubMed ID: 31514965
[TBL] [Abstract][Full Text] [Related]
59. Comparison of neutrophil-to-lymphocyte ratio and mean platelet volume in the prediction of adverse events after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction.
Machado GP; Araujo GN; Carpes CK; Lech M; Mariani S; Valle FH; Bergoli LCC; Gonçalves SC; Wainstein RV; Wainstein MV
Atherosclerosis; 2018 Jul; 274():212-217. PubMed ID: 29803159
[TBL] [Abstract][Full Text] [Related]
60. Application of neutrophil/lymphocyte ratio in predicting coronary blood flow and mortality in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention.
Pan W; Zhao D; Zhang C; Li W; Yu J; Wang S; Li Z; Wang Z; Sun X; Liu H; Sun Y; Tian Y; Wang L
J Cardiol; 2015 Jul; 66(1):9-14. PubMed ID: 25560801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
